Autori: Tiede Andreas
| Naslov | Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A (Article) |
| Autori | Tiede Andreas Rosa Cid Ana Goldmann Georg Jimenez-Yuste Victor Pluta Michael Lissitchkov Toshko May Marcus Matytsina Irina Miljic Predrag S Pabinger Ingrid Persson Paula |
| Info | THROMBOSIS AND HAEMOSTASIS, (2020), vol. 120 br. 2, str. 277-288 |
| Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark)Novo Nordisk |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial (Article) |
| Autori | Lentz Steven R Janic Dragana M Kavakli Kaan Miljic Predrag S Oldenburg Johannes Ozelo Margareth Castro Santagostino Elena Suzuki Takashi Zupancic-Salek Silva Korsholm Lars Matytsina Irina Tiede Andreas |
| Info | HAEMOPHILIA, (2018), vol. 24 br. 6, str. E391-E394 |
| Projekat | Novo Nordisk A/S |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy (Article) |
| Autori | Lentz SR Misgav M Ozelo MC Salek SZ Veljkovic Dobrila K Recht M Cerqueira MH Tiede Andreas Brand B Mancuso ME Seremetis S Lindblom A Martinowitz U |
| Info | HAEMOPHILIA, (2013), vol. 19 br. 5, str. 691-697 |
| Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
